We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Old Red Blood Cells May Double Mortality in Trauma Patients

By LabMedica International staff writers
Posted on 07 Oct 2009
Severe trauma patients requiring a major blood transfusion are twice as likely to die if they receive red blood cells (RBCs) stored for a month or longer, according to a new study.

Researchers at the Connecticut Children's Medical Center (Hartford, USA) conducted a retrospective cohort study that included 202 patients with traumatic injuries that compared patients transfused with one or more units of RBCs with a maximum storage age of up to 27 days, to those transfused with one or more RBC units with a maximum storage age greater than or equal to 28 days. More...
These study groups were also matched by the amount of units transfused. Primary outcomes were deep vein thrombosis (DVT) and in-hospital mortality.

The researchers found that in the decreased RBC storage age group, DVT occurred in 16.7% of the patients, compared to 34.5% in the increased storage group. Mortality was 13.9% compared 26.7%, respectively. Patients transfused RBCs of increased storage age had an independent association with mortality, and had an increased incidence of death from multi-organ failure (16%), compared to the decreased RBC age group (7%). The study was published in the September 22, 2009, issue of the open access journal Critical Care, a publication of BioMed Central.

"The preferential use of younger RBCs to critically ill patients has the potential to increase waste due to outdating,” said lead author Philip Spinella, M.D. "Since blood is often a scarce resource this is important and methods need to be developed to minimize waste while providing the most efficacious and safe blood product for a given patient.”

Related Links:

Connecticut Children's Medical Center




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.